Robert Korngold, PhD, chief of The Division of Research at John Theurer Cancer Center, reflects on the progress made in the field of bone marrow transplant. Most strikingly, new approaches have opened the opportunity of a bone marrow transplant to virtually all eligible patients, he noted.

Bone marrow transplants have become the platform from which immunotherapy and vaccines can be built, Korngold believes. New methods and approaches are becoming available, which lend strength to the graph versus tumor response in the hope of avoiding relapses and complications.

View more from the 2017 BMT Tandem Meetings

Videos

Robert Korngold, PhD, John Theurer Cancer Center looks back on the advances we've made so far in bone marrow transplant.

Robert Korngold, PhD

Articles

Robert Korngold on Advances in Bone Marrow Transplant